A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience
- PMID: 30753206
- PMCID: PMC6372177
- DOI: 10.1371/journal.pone.0212029
A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience
Abstract
Background: The emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) resulted in the recommended use of clindamycin and trimethoprim-sulfamethoxazole (TMP-SMX) for suspected S. aureus infections. The objective of this study was to determine the resistance to methicillin, clindamycin, and TMP-SMX in S. aureus isolates during a 10-year period.
Methods: Retrospective review of the antimicrobial susceptibilities of all S. aureus isolates in the outpatient and inpatient settings at Nationwide Children's Hospital from 1/1/2005 to 12/31/2014. Duplicate isolates from the same site and year and those obtained for MRSA surveillance or from patients with cystic fibrosis were excluded.
Results: Of the 57,788 S. aureus isolates from 2005-2014, 40,795 (71%) were included. In the outpatient setting, methicillin resistance decreased from 54% to 44% (p<0.001) while among inpatient isolates, no significant change was observed. From 2009-2014, resistance to clindamycin among outpatient isolates increased from 16% to 17% (p = 0.002) but no significant trend was observed among inpatient isolates (18% to 22%). Similarly, TMP-SMX resistance increased in outpatient S. aureus isolates from 2005-2014 (0.9% to 4%, p<0.001) but not among inpatient isolates. Among both inpatient and outpatient isolates, methicillin-susceptible S. aureus (MSSA) exhibited higher resistance to both clindamycin and TMP-SMX than MRSA. In addition, resistance to methicillin, clindamycin and TMP-SMX varied widely according to the site of specimen collection.
Conclusion: In a decade where >40,000 S. aureus isolates were identified at a large pediatric hospital, substantial changes in methicillin, clindamycin, and TMP-SMX resistance occurred. These findings highlight the importance of ongoing surveillance of the local antimicrobial resistance in S. aureus in order to guide empiric antimicrobial therapy.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities.Pediatr Infect Dis J. 2005 Jul;24(7):622-6. doi: 10.1097/01.inf.0000171175.76673.64. Pediatr Infect Dis J. 2005. PMID: 15999004
-
Antimicrobial Resistance Patterns of Outpatient Staphylococcus aureus Isolates.JAMA Netw Open. 2024 Jun 3;7(6):e2417199. doi: 10.1001/jamanetworkopen.2024.17199. JAMA Netw Open. 2024. PMID: 38874923 Free PMC article.
-
Antimicrobial resistance profile of methicillin-resistant Staphylococcus aureus isolates in children reported from the ISPED surveillance of bacterial resistance, 2016-2021.Front Cell Infect Microbiol. 2023 Jan 19;13:1102779. doi: 10.3389/fcimb.2023.1102779. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36743309 Free PMC article.
-
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.Pharmacotherapy. 2005 Feb;25(2):253-64. doi: 10.1592/phco.25.2.253.56956. Pharmacotherapy. 2005. PMID: 15767239 Review.
-
Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children.Curr Opin Infect Dis. 2003 Jun;16(3):265-9. doi: 10.1097/00001432-200306000-00014. Curr Opin Infect Dis. 2003. PMID: 12821819 Review.
Cited by
-
Clinical Outcomes of Oral Antibiotic Switch in Children with Staphylococcus aureus Bacteremia.Turk Arch Pediatr. 2024 Sep 2;59(5):469-475. doi: 10.5152/TurkArchPediatr.2024.24108. Turk Arch Pediatr. 2024. PMID: 39440396 Free PMC article.
-
A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus.PLoS One. 2022 Mar 24;17(3):e0265774. doi: 10.1371/journal.pone.0265774. eCollection 2022. PLoS One. 2022. PMID: 35324969 Free PMC article.
-
Inhibitor design to target a unique feature in the folate pocket of Staphylococcus aureus dihydrofolate reductase.Eur J Med Chem. 2020 Aug 15;200:112412. doi: 10.1016/j.ejmech.2020.112412. Epub 2020 May 20. Eur J Med Chem. 2020. PMID: 32502861 Free PMC article.
-
Improving the antimicrobial efficacy against resistant Staphylococcus aureus by a combined use of conjugated oligoelectrolytes.PLoS One. 2019 Nov 15;14(11):e0224816. doi: 10.1371/journal.pone.0224816. eCollection 2019. PLoS One. 2019. PMID: 31730663 Free PMC article.
-
Decreased Incidence of Methicillin-Resistant Staphylococcus aureus Bacteremia in Intensive Care Units: a 10-Year Clinical, Microbiological, and Genotypic Analysis in a Tertiary Hospital.Antimicrob Agents Chemother. 2020 Sep 21;64(10):e01082-20. doi: 10.1128/AAC.01082-20. Print 2020 Sep 21. Antimicrob Agents Chemother. 2020. PMID: 32747360 Free PMC article.
References
-
- Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279(8):593–8. . - PubMed
-
- Buckingham SC, McDougal LK, Cathey LD, Comeaux K, Craig AS, Fridkin SK, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children’s Hospital. Pediatr Infect Dis J. 2004;23(7):619–24. . - PubMed
-
- Fergie JE, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J. 2001;20(9):860–3. . - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical